Modulators of THR-β and methods of use thereof
US11840532B2 · kind B2 · utility
0Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2021 |
| Grant date | Dec 12, 2023 |
| Priority date | — |
| Expiry date | Dec 3, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds of Formula I′: or a stereoisomer or a tautomer thereof, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising such compounds, and methods of treating disease by administering or contacting a patient with one or more of the above compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.